Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Axogen Inc
(NQ:
AXGN
)
8.080
+0.310 (+3.99%)
Streaming Delayed Price
Updated: 3:48 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Axogen Inc
< Previous
1
2
Next >
Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results
March 05, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024
February 13, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
February 02, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap
January 18, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023
January 04, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025
January 04, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Axogen Announces Promotions on Research and Development Team
January 04, 2024
Company Also Announces Departure of Angelo Scopelianos, Ph.D.
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. Appoints Kathy Weiler to its Board of Directors
December 26, 2023
Weiler brings 20+ years of strategic and commercial leadership experience to the Axogen, Inc. Board of Directors
From
Axogen, Inc.
Via
GlobeNewswire
Axogen Announces Transition of Finance Team Leadership
December 06, 2023
Nir Naor Appointed CFO to Replace Peter Mariani as Company Aligns Executive Team with Financial Management Needs for Next Phase of Growth
From
Axogen, Inc.
Via
GlobeNewswire
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 01, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. to Participate at the Piper Sandler 35th Annual Healthcare Conference
November 20, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. Reports 2023 Third Quarter Financial Results
November 07, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. to Report Third Quarter 2023 Financial Results and Host Conference Call on November 7, 2023
October 18, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. Announces Full Launch of Axoguard HA+ Nerve Protector™
September 05, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen to Participate at Upcoming Investor Conferences
August 31, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. Begins Processing Avance® Nerve Graft at New State-of-the-Art Facility in Dayton, Ohio
August 21, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. Reports 2023 Second Quarter Financial Results
August 07, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen to Participate at Canaccord Genuity’s 43rd Annual Growth Conference
July 27, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. to report second quarter 2023 financial results and host conference call on August 7, 2023
July 26, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen to Participate at Jefferies Healthcare Conference
May 24, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen to Participate at JMP Securities Life Sciences Conference
May 12, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. Reports 2023 First Quarter Financial Results
May 09, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. to report first quarter 2023 financial results and host conference call on May 9, 2023
April 18, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc Reports 2022 Fourth Quarter and Full-Year Financial Results
March 14, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. Appoints Marc Began as Executive Vice President and General Counsel
March 06, 2023
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. to report fourth quarter 2022 financial results and host conference call on March 14, 2023
March 02, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen, Inc. Appoints Jens Schroeder Kemp as Chief Marketing Officer
February 13, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022
January 09, 2023
From
Axogen, Inc.
Via
GlobeNewswire
Axogen Announces Independent Publication of Comparative Nerve Gap Repair Meta-Analysis of 35 peer-reviewed studies of Allograft, Autograft, and Conduits
January 05, 2023
Study concluded allograft and autograft repairs delivered significantly better rates of meaningful sensory recovery in short gaps as compared to conduit repairs in a systematic meta-analysis including...
From
Axogen, Inc.
Via
GlobeNewswire
Axogen to Participate at J.P. Morgan 41st Annual Healthcare Conference
January 04, 2023
From
Axogen, Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.